BIOM BIOMOLECULAR LIFE HOLDINGS, INC.
Pharmaceutical Preparations · OTC · SEC CIK 1091326 · Fiscal year ends 12/31
Financial factors as of 2015-09-30 (2015Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY51.4%
TTM EPS YoY91.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-381.4%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets431.7%
Debt / equity—
Current ratio0.01x
Interest coverage-1.32x
Cash quality & payout
Operating cash flow / net income0.20x
Accruals ratio-305.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20142014-12-31 | FY20132013-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $0 |
| R&D expense | $865,702 | $808,517 |
| SG&A expense | $911,355 | $1.35M |
| Operating income | -$4.14M | -$3.91M |
| Interest expense | $2.76M | $1.08M |
| Income tax | $0 | $0 |
| Net income | -$6.19M | -$7.42M |
| EBITDA | -$4.14M | -$3.91M |
| EPS (basic) | -0.22 | -0.91 |
| EPS (diluted) | -0.22 | -0.91 |
| Weighted avg. shares (diluted) | 27.63M | 8.19M |
| Balance sheet | ||
| Cash & equivalents | $33,992 | $713,892 |
| Current assets | $246,266 | $789,386 |
| PP&E, net | $0 | $0 |
| Intangibles | $1.08M | $1.08M |
| Total assets | $1.32M | $1.87M |
| Current liabilities | $5.83M | $6.33M |
| Total liabilities | $5.16M | $5.64M |
| Shareholders' equity | -$4.51M | -$4.47M |
| Shares outstanding | 46.22M | 17.46M |
| Cash flow statement | ||
| Operating cash flow | -$1.91M | -$1.04M |
| Capital expenditure | $0 | $0 |
| Free cash flow | -$1.91M | -$1.04M |
| Investing cash flow | $0 | $0 |
| Financing cash flow | $1.23M | $1.75M |
| Depreciation & amortization | $0 | $0 |
| Stock-based compensation | $0 | $0 |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.